L-alanine producing microorganism and method for producing l-alanine using same

MYPI2025005451A0Undetermined Publication Date: 2024-09-10CJ CHEILJEDANG CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025005451
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-03-10
Filing Date
2024-03-06
Publication Date
2024-09-10

AI Technical Summary

Technical Problem

Current industrial production of L-alanine through chemical synthesis or enzymatic conversion is costly and inefficient due to reliance on petroleum-derived substrates and low yield, necessitating an alternative method for increased productivity.

Method used

Introduction of alanine dehydrogenase activity into Corynebacterium microorganisms, such as those from Bacillus licheniformis, Bacillus amyloliquefaciens, or Raceella sacchari, to enhance L-alanine production capacity.

Benefits of technology

The modified microorganisms demonstrate significantly increased L-alanine production ability, achieving higher yields compared to unmodified strains, thereby addressing the inefficiencies of traditional production methods.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present disclosure relates to a microorganism of the genus Corynebacterium having an L-alanine-producing ability, into which the activity of alanine dehydrogenase is introduced; a method for producing L-alanine, comprising culturing the microorganism in a medium; a composition for producing L-alanine, comprising the microorganism, a culture product of the microorganism, a fermented product of the microorganism, or a combination of two or more thereof; and the use of the microorganism for the production of L-alanine.
Need to check novelty before this filing date? Find Prior Art

Description

L-alanine producing microorganism and method for producing L-alanine using the same

[0001] The present application relates to a Corynebacterium genus microorganism having L-alanine production ability and having introduced alanine dehydrogenase activity; a method for producing L-alanine, comprising a step of culturing the microorganism in a medium; a composition for producing L-alanine, comprising the microorganism, a culture of the microorganism, a fermented product of the microorganism, or a combination of two or more thereof; and a use of the microorganism for producing L-alanine.

[0002]

[0003] L-alanine is an important amino acid with wide applications in fields such as chemistry, food, and medicine. As a sweet amino acid, it is particularly used in the food industry as a flavor enhancer and nutritional supplement. As of 2020, the global alanine market was valued at over USD 250 million, with an annual production of approximately 500 tons (The Expresswire, 2020; Wendisch, 2014).

[0004] In this regard, chemical synthesis or enzymatic conversion is mainly used to produce L-alanine. Chemical synthesis is achieved by modifying the Strecker synthesis or Bucherer-Bergs method (Legnani et al., 2021), and enzymatic conversion is obtained from L-aspartic acid with ammonium fumarate (Takamatsu et al., 1982). Most industrial production is achieved through enzymatic conversion processes, but the substrate L-aspartic acid is produced from petroleum, and the production of fumaric acid also depends on petroleum, which is costly and has the problem of low yield when replacing it.

[0005] Therefore, as an alternative, microbial fermentation can provide a rich carbon source at low cost. Naturally, microorganisms produce L-alanine using aminotransferase or alanine dehydrogenase. However, low productivity limits the production of L-alanine using naturally occurring strains.

[0006] Therefore, research is still needed to effectively increase L-alanine production.

[0007]

[0008] The present inventors completed the present application by confirming that when the activity of alanine dehydrogenase is introduced into a microorganism of the genus Corynebacterium, the L-alanine production ability is increased compared to an unmodified microorganism.

[0009]

[0010] One aspect of the present application provides a Corynebacterium genus microorganism having L-alanine production ability, into which alanine dehydrogenase activity has been introduced.

[0011] In one specific example, the alanine dehydrogenase may be from Bacillus licheniformis, Bacillus amyloliquefaciens, or Raceella sacchari.

[0012] In another specific example, the alanine dehydrogenase may be encoded by the ald1, ald2, or alaD gene.

[0013] In another specific embodiment, the alanine dehydrogenase may comprise an amino acid sequence of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, or SEQ ID NO: 7.

[0014] In another specific example, the gene encoding the alanine dehydrogenase may comprise the base sequence of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, or SEQ ID NO: 8.

[0015] As a microorganism according to any one of the preceding specific examples, the microorganism of the genus Corynebacterium may be Corynebacterium glutamicum.

[0016] As a microorganism according to any one of the preceding specific examples, the microorganism of the genus Corynebacterium may have an increased ability to produce L-alanine compared to a non-modified microorganism.

[0017] Another aspect of the present application provides a method for producing L-alanine, comprising the step of culturing a Corynebacterium genus microorganism having L-alanine production ability and having alanine dehydrogenase activity introduced therein, in a medium.

[0018] In one specific example, the alanine dehydrogenase may be from Bacillus licheniformis, Bacillus amyloliquefaciens, or Raceella sacchari.

[0019] In another specific embodiment, the method may additionally include a step of recovering a target substance from the cultured microorganism, a culture of the microorganism, a fermented product of the microorganism, or the culture medium.

[0020] Another aspect of the present application provides a composition for producing L-alanine, comprising a Corynebacterium genus microorganism having L-alanine production ability and having introduced alanine dehydrogenase activity, a culture of the microorganism, a fermented product of the microorganism, or a combination of two or more thereof.

[0021] In one specific example, the alanine dehydrogenase may be from Bacillus licheniformis, Bacillus amyloliquefaciens, or Raceella sacchari.

[0022] Another aspect of the present application provides a use of a microorganism of the genus Corynebacterium, into which the activity of alanine dehydrogenase has been introduced, for producing L-alanine.

[0023] In one specific example, the alanine dehydrogenase may be from Bacillus licheniformis, Bacillus amyloliquefaciens, or Raceella sacchari.

[0024]

[0025] The Corynebacterium genus microorganism having L-alanine production ability and having the activity of alanine dehydrogenase introduced in the present application can produce L-alanine at a high yield and can thus be usefully utilized in the industrial production of L-alanine.

[0026]

[0027] This is explained in detail as follows. Meanwhile, each description and embodiment disclosed in this application can also be applied to each other description and embodiment. In other words, all combinations of the various elements disclosed in this application fall within the scope of this application. Furthermore, the scope of this application is not limited by the specific descriptions described below.

[0028] Furthermore, those skilled in the art will recognize or be able to ascertain, using only routine experimentation, numerous equivalents to the specific embodiments of the present application described herein. Furthermore, such equivalents are intended to be encompassed by this application.

[0029] As used in the specification and appended claims of this application, the singular articles "a," "an," and "the" include plural references unless the context clearly dictates otherwise. Unless the context clearly dictates otherwise, the singular terms include the plural and the plural terms include the singular. In the specification and appended claims of this application, unless the context clearly dictates otherwise, the use of "or" is intended to include "and / or."

[0030]

[0031] In this application, the term "about" may be used before a specific numerical value. As used herein, the term "about" encompasses not only the exact number described after the term, but also a range that is or is nearly that number. Whether a number is or is nearly the specific number described can be determined based on the context in which it is presented. For example, the term "about" may refer to a range of -10% to +10% of a numerical value. In another example, the term "about" may refer to a range of -5% to +5% of a given numerical value. However, this is not a limitation.

[0032] In this application, the terms "first, second, third," "i), ii), iii)," or "(a), (b), (c), (d)," are used to distinguish similar configurations, and these terms do not imply that the steps are performed consecutively or in order. For example, when the terms are used in connection with steps of a method, use, or analysis, these steps may be performed simultaneously, or may be performed at intervals of seconds, minutes, hours, days, or months.

[0033] In this application, the term "consisting essentially of" means that a non-specific component may be present if the characteristics of the subject matter claimed in this application are not substantially affected by the presence of the non-specific component.

[0034] In this application, the term "consisting of" means that the proportion of a specific component(s) totals 100%. The components or features listed below the term "consisting of" may be essential or mandatory. In some embodiments, other than the components or features listed below "consisting of," other optional or nonessential components may be excluded.

[0035] In this application, the term "comprising" means the presence of a feature, step, or component described below, and does not exclude the presence or addition of one or more features, steps, or components. The components or features described below "comprising" in this application may be essential or mandatory, but in some embodiments, other optional or non-essential components or features may be further included.

[0036]

[0037] One aspect of the present application provides a Corynebacterium genus microorganism having L-alanine production ability, into which alanine dehydrogenase activity has been introduced.

[0038] In one specific example, the alanine dehydrogenase may be from Bacillus licheniformis, Bacillus amyloliquefaciens, or Raceella sacchari.

[0039] The activity of the above alanine dehydrogenase may be defined as an increased L-alanine production ability of a microorganism into which the activity of the alanine dehydrogenase of the present application has been introduced, compared to the production ability of a natural wild-type microorganism or an unmodified microorganism (e.g., a strain before the activity of the alanine dehydrogenase of the present application has been introduced), but is not limited thereto.

[0040] For example, the activity of the alanine dehydrogenase can be measured by measuring the L-alanine productivity or yield, but is not limited thereto.

[0041]

[0042] In this application, the term "alanine dehydrogenase" means an oxidation / reduction enzyme that catalyzes the reversible conversion of L-alanine from pyruvate with the coenzyme NAD+ / NADH.

[0043] Specifically, the alanine dehydrogenase of the present application may be a protein having alanine dehydrogenase activity encoded by the ald1, ald2, or alaD gene, but is not particularly limited in type as long as it has an activity corresponding to alanine dehydrogenase and can be introduced into a microorganism of the genus Corynebacterium to improve the productivity of L-alanine. The alanine dehydrogenase encoded by the ald1, ald2, or alaD gene is known in the art, and the amino acid and polynucleotide sequences of the alanine dehydrogenase can be obtained from a known database, such as, but not limited to, NCBI's GenBank.

[0044] In the present application, the alanine dehydrogenase may be, but is not limited to, an alanine dehydrogenase derived from Bacillus licheniformis, Bacillus amyloliquefaciens, or Laceyella sacchari.

[0045] The alanine dehydrogenase derived from Bacillus licheniformis presented as an example in the present application may be a protein comprising an amino acid sequence of SEQ ID NO: 1 or SEQ ID NO: 3, but is not limited thereto. The alanine dehydrogenase derived from Bacillus amyloliquefaciens may be a protein comprising an amino acid sequence of SEQ ID NO: 5, but is not limited thereto. The alanine dehydrogenase derived from Laceyella sacchari may be a protein comprising an amino acid sequence of SEQ ID NO: 7, but is not limited thereto.

[0046] For example, in the present application, the protein having alanine dehydrogenase activity may be, but is not limited to, a protein comprising an alanine dehydrogenase amino acid sequence (SEQ ID NO: 1 or SEQ ID NO: 3) derived from Bacillus licheniformis, an alanine dehydrogenase amino acid sequence (SEQ ID NO: 5) derived from Bacillus amyloliquefaciens, or an alanine dehydrogenase amino acid sequence (SEQ ID NO: 7) derived from Laceyella sacchari.

[0047] For example, the alanine dehydrogenase may include an amino acid sequence of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, or SEQ ID NO: 7 or an amino acid sequence having at least 60% homology or identity therewith, but is not limited thereto, as long as it has alanine dehydrogenase activity. Specifically, the polypeptide having the alanine dehydrogenase activity may have, include, consist of, or consist essentially of an amino acid sequence of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, or SEQ ID NO: 7; or an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% homology or identity therewith to SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, or SEQ ID NO: 7.

[0048] In the present application, with respect to the amino acid sequence, even if it is described as a polypeptide “comprising” the amino acid sequence set forth in a specific sequence number, a polypeptide “consisting of” the amino acid sequence set forth in a specific sequence number, or a polypeptide or protein “having” the amino acid sequence set forth in a specific sequence number, it is obvious that a protein having an amino acid sequence in which a portion of the sequence is deleted, modified, substituted, conservatively substituted, or added is also included within the scope of the present application, as long as it has the same or corresponding activity as the protein consisting of the amino acid sequence of the corresponding sequence number. For example, if it has the same or corresponding activity as the above-mentioned mutant protein, it does not exclude sequence additions that do not alter the function of the protein before or after the amino acid sequence, mutations that may occur naturally, silent mutations thereof, or conservative substitutions, and it is obvious that even if it has such sequence additions or mutations, it is also within the scope of the present application.

[0049] For example, the variant polypeptide of the present invention may have sequence additions, naturally occurring mutations, silent mutations, or conservative substitutions at the N-terminus, C-terminus, and / or within the amino acid sequence that do not alter the function of the polypeptide. For example, the polypeptide may be conjugated to a signal (or leader) sequence at the N-terminus of a protein that is involved in the transfer of the protein co-translationally or post-translationally. Furthermore, the polypeptide may be conjugated to other sequences or linkers so that the polypeptide can be identified, purified, or synthesized.

[0050] In this application, the term "conservative substitution" refers to the replacement of one amino acid with another amino acid having similar structural and / or chemical properties. Such amino acid substitutions may generally occur based on similarities in the polarity, charge, solubility, hydrophobicity, hydrophilicity, and / or amphipathic nature of the residues. For example, positively charged (basic) amino acids include arginine, lysine, and histidine; negatively charged (acidic) amino acids include glutamic acid and aspartic acid; and amino acids with nonpolar side chains (nonpolar amino acids) include glycine, alanine, valine, leucine, isoleucine, methionine, phenylalanine, tryptophan, and proline; Amino acids with polar or hydrophilic side chains (polar amino acids) include serine, threonine, cysteine, tyrosine, asparagine, and glutamine. As another example, amino acids with charged side chains include arginine, lysine, histidine, glutamic acid, and aspartic acid, while amino acids with uncharged side chains (also called neutral amino acids) include glycine, alanine, valine, leucine, isoleucine, methionine, phenylalanine, tryptophan, proline, serine, threonine, cysteine, tyrosine, asparagine, and glutamine. As another example, phenylalanine, tryptophan, and tyrosine can be classified as aromatic amino acids. As another example, valine, leucine, and isoleucine can be classified as branched amino acids.As another example, the 20 amino acids can be classified into five groups based on size: glycine, alanine, and serine; cysteine, proline, threonine, aspartic acid, and asparagine; valine, histidine, glutamic acid, and glutamine; isoleucine, leucine, methionine, lysine, and arginine; and phenylalanine, tryptophan, and tyrosine. However, this is not necessarily limited to these groups. Typically, conservative substitutions may have little or no effect on the activity of the polypeptide.

[0051]

[0052] In addition, the base sequence encoding the alanine dehydrogenase may be a base sequence encoding a protein that exhibits the activity of alanine dehydrogenase and whose activity is introduced into a microorganism of the genus Corynebacterium to enhance the production ability of L-alanine. For example, it may be a base sequence encoding an alanine dehydrogenase derived from Bacillus licheniformis (SEQ ID NO: 1 or SEQ ID NO: 3), an alanine dehydrogenase derived from Bacillus amyloliquefaciens (SEQ ID NO: 5), or an alanine dehydrogenase derived from Laceyella sacchari (SEQ ID NO: 7), but is not limited thereto.

[0053] For example, an alanine dehydrogenase having an amino acid sequence of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, or SEQ ID NO: 7 may be encoded by a polynucleotide having, including, consisting of, or consisting essentially of a base sequence of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, or SEQ ID NO: 8; or having at least 60%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, and less than 100% homology or identity with a base sequence of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, or SEQ ID NO: 8, but is not limited thereto. Additionally, the base sequence of the above sequence number 2, sequence number 4, sequence number 6, or sequence number 8 can be obtained from a known database, such as, but not limited to, NCBI's GenBank.

[0054] In the present application, the gene comprising the base sequence of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, or SEQ ID NO: 8 may be used interchangeably with a polynucleotide comprising the base sequence of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, or SEQ ID NO: 8, a gene or polynucleotide having the base sequence of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, or SEQ ID NO: 8, or a gene or polynucleotide consisting of the base sequence of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, or SEQ ID NO: 8.

[0055] The polynucleotide of the present application may undergo various modifications in the coding region without altering the amino acid sequence of the alanine dehydrogenase of the present application due to codon degeneracy or in consideration of the codons preferred in the organism that is intended to express the alanine dehydrogenase of the present application. Therefore, it is obvious that the polynucleotide of the present application may also be included, which can be translated into a polypeptide consisting of the amino acid sequence of the alanine dehydrogenase of the present application or a polypeptide having homology or identity therewith due to codon degeneracy. For example, the polynucleotide of the present application may be SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, or SEQ ID NO: 8; or a degenerated sequence thereof.

[0056] In addition, the polynucleotide of the present application may include, without limitation, a probe that can be prepared from a known gene sequence, for example, a sequence that hybridizes under stringent conditions with a complementary sequence to all or part of the polynucleotide sequence of the present application, as long as it is a sequence encoding the alanine dehydrogenase of the present application.

[0057] As used herein, the terms "homology" or "identity" refer to the degree to which two given amino acid sequences or base sequences are related, which may be expressed as a percentage. The terms homology and identity are often used interchangeably.

[0058] Sequence homology or identity of conserved polynucleotides or polypeptides is determined by standard alignment algorithms, and may be combined with default gap penalties established by the program being used. In practice, homologous or identical sequences are generally capable of hybridizing under moderate or high stringency conditions, typically along at least about 50%, 60%, 70%, 80%, or 90% of the entire sequence or its entire length. It should be appreciated that hybridization also encompasses polynucleotides containing common codons or codons considered codon degeneracy.

[0059] Whether any two polynucleotide or polypeptide sequences are homologous, similar or identical can be determined using known computer algorithms such as the "FASTA" program using default parameters, for example as in Pearson et al (1988) [Proc. Natl. Acad. Sci. USA 85]: 2444. Alternatively, the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, J. Mol. Biol. 48: 443-453) as implemented in the Needleman program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et al., 2000, Trends Genet. 16: 276-277) (version 5.0.0 or later) can be determined using the GCG program package (Devereux, J., et al, Nucleic Acids Research 12: 387 (1984)), BLASTP, BLASTN, FASTA (Atschul, [S.] [F.,] [ET AL, J MOLEC BIOL 215]: 403 (1990); Guide to Huge Computers, Martin J. Bishop, [ED.,] Academic Press, San Diego, 1994, and [CARILLO et al.](1988) SIAM J Applied Math 48: 1073). For example, homology, similarity, or identity can be determined using BLAST or ClustalW from the National Center for Biotechnology Information database.

[0060] Homology, similarity or identity of polynucleotides or polypeptides can be determined by comparing sequence information using, for example, the GAP computer program disclosed in Smith and Waterman, Adv. Appl. Math (1981) 2:482, or, for example, Needleman et al. (1970), J Mol Biol. 48:443. In brief, the GAP program can be defined as the total number of symbols in the shorter of the two sequences divided by the number of similarly arranged symbols (i.e., nucleotides or amino acids). The default parameters for the GAP program are (1) unitary matrices (containing values ​​of 1 for identity and 0 for non-identity), the PAM Matrix (see the disclosure by Schwartz and Dayhoff, eds., Atlas Of Protein Sequence And Structure, National Biomedical Research Foundation (1978)), Gribskov et al (1986) Nucl. Acids Res. 14: 6745 weighted comparison matrix (or EDNAFULL (EMBOSS version of NCBI NUC4.4) permutation matrix); (2) a penalty of 3.0 for each gap and an additional penalty of 0.10 for each symbol in each gap (or a gap opening penalty of 10, a gap extension penalty of 0.5); and (3) no penalty for terminal gaps.

[0061] Additionally, whether any two polynucleotide or polypeptide sequences have homology, similarity or identity can be determined by comparing the sequences by Southern hybridization experiments under defined stringent conditions, and the defined appropriate hybridization conditions are within the scope of the art and can be determined by methods well known to those skilled in the art (e.g., J. Sambrook et al., Molecular Cloning, A Laboratory Manual; F. M. Ausubel et al., Current Protocols in Molecular Biology, John Wiley & Sons, Inc., New York), but are not limited thereto.

[0062] In this application, the term "stringent conditions" refers to conditions that allow specific hybridization between polynucleotides. Such conditions are specifically described in the literature (see Sambrook et al., supra, 9.50-9.51, 11.7-11.8). For example, conditions in which polynucleotides having high homology or identity hybridize with each other, polynucleotides having 60% or more, 70% or more, 75% or more, 80% or more, 85% or more, 90% or more, 95% or more, 96% or more, 97% or more, 98% or more, or 99% or more homology or identity hybridize with each other, and polynucleotides having lower homology or identity do not hybridize with each other, or conditions in which washing is performed once, specifically twice or three times, at a salt concentration and temperature equivalent to 60°C, 1ХSSC, 0.1% SDS, specifically 60°C, 0.1ХSSC, 0.1% SDS, and more specifically 68°C, 0.1ХSSC, 0.1% SDS, which are washing conditions of typical southern hybridization, are performed.

[0063] The above hybridization requires that the two nucleotides have complementary sequences, although mismatches between bases are possible depending on the stringency of the hybridization. The term "complementary" is used to describe the relationship between nucleotide bases that can hybridize with each other. For example, in DNA, adenosine is complementary to thymine, and cytosine is complementary to guanine. Accordingly, the polynucleotide of the present application may also include isolated nucleic acid fragments that are complementary in their entirety, as well as those with substantially similar base sequences.

[0064] For example, a polynucleotide having homology or identity with the polynucleotide of the present application can be detected using hybridization conditions including a hybridization step at a Tm value of 55°C and using the conditions described above. In addition, the Tm value may be, but is not limited to, 60°C, 63°C, or 65°C, and can be appropriately adjusted by a person skilled in the art depending on the purpose.

[0065] The appropriate stringency for hybridizing the polynucleotides depends on the length and degree of complementarity of the polynucleotides, variables which are well known in the art (e.g., J. Sambrook et al., supra).

[0066]

[0067] In this application, the term "L-alanine" means an L-amino acid having the chemical formula HO2CCH(NH2)CH3, which is one of the essential amino acids.

[0068]

[0069] In this application, the term "microorganism (or strain)" includes both wild-type microorganisms and microorganisms that have undergone genetic modification, either naturally or artificially. It may be a microorganism that has a specific mechanism weakened or increased due to causes such as the insertion of an external gene or the increased or inactivated activity of an endogenous gene, and may be a microorganism that includes genetic modification for the production of a desired polypeptide, protein, or product. In this application, "microorganism" and "strain" may be used interchangeably without limitation with the same meaning.

[0070] For example, the microorganism of the present application may be a microorganism (e.g., a recombinant strain) into which the activity of alanine dehydrogenase has been introduced, but is not limited thereto.

[0071] In the present application, the term "microorganism having L-alanine production ability" refers to a prokaryotic or eukaryotic microbial strain capable of producing L-alanine within the organism, and may include both a microorganism in which the L-alanine production ability is conferred on a parent strain that does not have L-alanine production ability, and a microorganism that inherently has L-alanine production ability. The L-alanine production ability may be conferred or enhanced by species improvement.

[0072] In this application, the term "unmodified microorganism" does not exclude a strain that contains a mutation that can occur naturally in a microorganism, and may refer to a wild-type strain or a natural strain itself, or a strain before its characteristics are changed by genetic mutation due to natural or artificial factors. The "unmodified microorganism" may be used interchangeably with "pre-modified strain", "pre-modified microorganism", "unmutated strain", "unmodified strain", "unmutated microorganism", "pre-mutated parent strain", "wild-type microorganism", "reference microorganism", or "reference microorganism". In this application, the unmodified microorganism may refer to a strain in which the activity of the alanine dehydrogenase of the present application is not introduced, or before the activity of the alanine dehydrogenase is introduced, but is not limited thereto. Additionally, in the present application, the unmodified microorganism may be a microorganism that does not include the amino acid sequence of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, or SEQ ID NO: 7 or the base sequence of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, or SEQ ID NO: 8, but is not limited thereto.

[0073]

[0074] For the purposes of the present application, the microorganism of the present application may include any microorganism capable of producing the desired L-alanine by introducing the activity of alanine dehydrogenase. For example, the microorganism of the present application is characterized by increased L-alanine productivity by introducing the activity of alanine dehydrogenase, and may be a genetically modified microorganism or a recombinant microorganism, but is not limited thereto. Specifically, the recombinant strain with increased L-alanine productivity may be a microorganism with increased L-alanine productivity compared to a natural wild-type microorganism or an unmodified microorganism having the intrinsic activity of alanine dehydrogenase, but is not limited thereto.

[0075] For example, a microorganism having L-alanine production ability may be a prokaryotic or eukaryotic microorganism strain capable of producing L-alanine within the organism, and may include both a microorganism having an inherent L-alanine production ability or a microorganism that has been endowed with L-alanine production ability due to the alanine dehydrogenase activity introduced in the present application to a parent strain that does not have L-alanine production ability. The L-alanine production ability may be endowed or enhanced by species improvement.

[0076] The microorganism of the present application may include any microorganism into which alanine dehydrogenase activity has been introduced by various known methods.

[0077]

[0078] In this application, the term "introduction" of activity refers to the expression of a gene not originally present in a microorganism, thereby causing the activity of a specific protein to be exhibited, or the enhancement, increase, or improvement of polypeptide activity compared to the inherent activity of the protein or the activity prior to modification. For example, a polynucleotide encoding a specific protein may be introduced into the chromosome of a microorganism, or a vector containing a polynucleotide encoding a specific protein may be introduced into the microorganism, resulting in the exhibiting of its activity.

[0079] The above “intrinsic activity” refers to the activity of a specific polypeptide originally possessed by the parent strain or unmodified microorganism before the change in trait when the trait is changed due to genetic mutation caused by natural or artificial factors. This may be used interchangeably with “activity before modification.”

[0080] In this application, the term "enhancement" of polypeptide activity means that the activity of the polypeptide is increased compared to the intrinsic activity. The enhancement may be used interchangeably with terms such as activation, up-regulation, overexpression, and increase. Here, activation, enhancement, up-regulation, overexpression, and increase may all include exhibiting an activity that was not originally present, or exhibiting an enhanced activity compared to the intrinsic activity or the activity before modification. "Enhancement," "up-regulation," "overexpression," or "increase" of the activity of a polypeptide compared to the intrinsic activity means that the activity and / or concentration (expression amount) of a specific polypeptide is enhanced compared to the activity and / or concentration (expression amount) that the parent strain or unmodified microorganism originally had before the transformation. For example, the "exhibiting an activity that was not originally present" may be, but is not limited to, "introduction of a protein."

[0081] Enhancement of the activity of a polypeptide compared to its intrinsic activity means that the activity and / or concentration (expression amount) of a specific polypeptide is enhanced compared to the activity and / or concentration (expression amount) that the parent strain or unmodified microorganism originally had before the transformation.

[0082] For example, the enhancement may be, but is not limited to, an increase in the activity or concentration of the corresponding protein from a previously absent activity to a concentration of about 1%, about 10%, about 25%, about 50%, about 75%, about 100%, about 150%, about 200%, about 300%, about 400%, or about 500%, up to about 1000% or more, relative to the activity or concentration in the wild-type protein or the initial microbial strain. The term “about” includes, but is not limited to, ±0.5, ±0.4, ±0.3, ±0.2, ±0.1, etc., and includes all numerical values ​​in a range equal to or similar to the numerical value following the term “about.”

[0083] The above enhancement can be achieved by introducing an exogenous polypeptide, or by enhancing the activity and / or concentration (expression level) of an endogenous polypeptide. Whether the activity of the polypeptide is enhanced can be determined by an increase in the level of activity, expression level, or amount of product excreted from the polypeptide.

[0084] Enhancement of the activity of the above polypeptide can be achieved by applying various methods well known in the art, and is not limited as long as the activity of the target polypeptide can be enhanced compared to that of the microorganism before modification. Specifically, it may be achieved by using genetic engineering and / or protein engineering, which are routine methods of molecular biology and are well known to those skilled in the art, but is not limited thereto (e.g., Sitnicka et al. Functional Analysis of Genes. Advances in Cell Biology. 2010, Vol. 2. 1-16, Sambrook et al. Molecular Cloning 2012, etc.).

[0085] Specifically, the enhancement of the polypeptide of the present application is

[0086] 1) Increase in the intracellular copy number of a polynucleotide encoding a polypeptide;

[0087] 2) Modification of the gene expression control region on the chromosome encoding the polypeptide (e.g., mutation in the expression control region, replacement with a sequence having stronger activity, or insertion of a sequence having stronger activity);

[0088] 3) Modification of the base sequence encoding the initiation codon or 5'-UTR region of a gene transcript encoding a polypeptide;

[0089] 4) Modification of the amino acid sequence of the polypeptide so as to enhance polypeptide activity;

[0090] 5) Modification of the polynucleotide sequence encoding the polypeptide so as to enhance the activity of the polypeptide (e.g., modification of the polynucleotide sequence of the polypeptide gene so as to encode a polypeptide modified so as to enhance the activity of the polypeptide);

[0091] 6) Introduction of a foreign polypeptide exhibiting the activity of the polypeptide or a foreign polynucleotide encoding the same;

[0092] 7) Codon optimization of a polynucleotide encoding a polypeptide;

[0093] 8) Analyzing the tertiary structure of the polypeptide and selecting the exposed portion to modify or chemically modify; or

[0094] 9) It may be a combination of two or more of the above 1) to 8), but is not particularly limited thereto.

[0095] More specifically,

[0096] The increase in the intracellular copy number of the polynucleotide encoding the polypeptide described above may be achieved by introducing into the host cell a vector capable of replicating and functioning independently of the host, to which the polynucleotide encoding the polypeptide is operably linked. Alternatively, the polynucleotide encoding the polypeptide may be achieved by introducing one copy or two or more copies into the chromosome of the host cell. The introduction into the chromosome may be performed by introducing into the host cell a vector capable of inserting the polynucleotide into the chromosome of the host cell, but is not limited thereto. The vector is as described above.

[0097] 2) Replacing the gene expression control region (or expression control sequence) on the chromosome encoding the polypeptide with a sequence having strong activity may be, for example, a mutation in the sequence such as deletion, insertion, non-conservative or conservative substitution, or a combination thereof to further enhance the activity of the expression control region, or replacement with a sequence having stronger activity. The expression control region may include, but is not particularly limited to, a promoter, an operator sequence, a sequence encoding a ribosome binding site, and a sequence regulating the termination of transcription and translation. As an example, it may be, but is not limited to, replacing the original promoter with a strong promoter.

[0098] Examples of known strong promoters include, but are not limited to, the CJ1 to CJ7 promoters (US Patent No. US 7662943 B2), the lac promoter, the trp promoter, the trc promoter, the tac promoter, the lambda phage PR promoter, the PL promoter, the tet promoter, the gapA promoter, the SPL7 promoter, the SPL13 (sm3) promoter (US Patent No. US 10584338 B2), the O2 promoter (US Patent No. US 10273491 B2), the tkt promoter, and the yccA promoter.

[0099] The above 3) modification of the base sequence encoding the initiation codon or 5'-UTR region of the gene transcript encoding the polypeptide may be, for example, a substitution with a base sequence encoding another initiation codon having a higher polypeptide expression rate than the endogenous initiation codon, but is not limited thereto.

[0100] The modification of the amino acid sequence or polynucleotide sequence of the above 4) and 5) may be, but is not limited to, a mutation in the sequence by deletion, insertion, non-conservative or conservative substitution, or a combination thereof in the amino acid sequence of the polypeptide or the polynucleotide sequence encoding the polypeptide to enhance the activity of the polypeptide, or replacement with an amino acid sequence or polynucleotide sequence improved to have stronger activity, or an amino acid sequence or polynucleotide sequence improved to have increased activity. The replacement may be specifically performed by inserting the polynucleotide into a chromosome by homologous recombination, but is not limited thereto. The vector used at this time may additionally include a selection marker to confirm whether or not the chromosome has been inserted. The selection marker is as described above.

[0101] The introduction of the foreign polynucleotide exhibiting the activity of the polypeptide as described above 6) may be the introduction into the host cell of a foreign polynucleotide encoding a polypeptide exhibiting the same / similar activity as the polypeptide. The foreign polynucleotide is not limited in its origin or sequence as long as it exhibits the same / similar activity as the polypeptide. The method used for the introduction may be performed by a person skilled in the art by appropriately selecting a known transformation method, and the polypeptide may be produced by expressing the introduced polynucleotide in the host cell, thereby increasing its activity.

[0102] The above 7) codon optimization of a polynucleotide encoding a polypeptide may be codon optimization of an endogenous polynucleotide to increase transcription or translation within a host cell, or codon optimization of a foreign polynucleotide to achieve optimized transcription or translation within a host cell.

[0103] The above 8) analyzing the tertiary structure of a polypeptide and selecting an exposed portion to modify or chemically modify may be done by, for example, comparing the sequence information of the polypeptide to be analyzed with a database storing the sequence information of known proteins, determining a template protein candidate based on the degree of sequence similarity, confirming the structure based on this, and selecting an exposed portion to modify or chemically modify, and modifying or modifying it.

[0104] Such enhancement of polypeptide activity may be, but is not limited to, an increase in the activity or concentration or expression level of the corresponding polypeptide relative to the activity or concentration of the polypeptide expressed in the wild type or pre-transformed microbial strain, or an increase in the amount of a product produced from the polypeptide.

[0105]

[0106] For example, the recombinant microorganism having L-alanine production ability of the present application may include any microorganism capable of producing L-alanine by being transformed through a vector and introducing a foreign gene encoding the alanine dehydrogenase of the present application, specifically, a foreign gene encoding the alanine dehydrogenase derived from Bacillus licheniformis, Bacillus amyloliquefaciens, or Laceyella sacchari.

[0107]

[0108] For the purposes of the present application, the microorganism may include an expression vector for expressing the foreign polynucleotide in a host, thereby enhancing the alanine dehydrogenase protein activity compared to the endogenous activity, but is not limited thereto.

[0109] The vector of the present application may comprise a DNA construct comprising a base sequence of a polynucleotide encoding a target polypeptide operably linked to a suitable expression control region (or expression control sequence) so as to enable expression of the target polypeptide in a suitable host. The expression control region may comprise a promoter capable of initiating transcription, an optional operator sequence for regulating such transcription, a sequence encoding a suitable mRNA ribosome binding site, and sequences regulating the termination of transcription and translation. The vector may be capable of replicating or functioning independently of the host genome after being transformed into a suitable host cell, or may be integrated into the genome itself.

[0110] The vector used in the present application is not particularly limited, and any vector known in the art can be used. Examples of commonly used vectors include plasmids, cosmids, viruses, and bacteriophages in a natural or recombinant state. For example, pWE15, M13, MBL3, MBL4, IXII, ASHII, APII, t10, t11, Charon4A, and Charon21A can be used as phage vectors or cosmid vectors, and pDZ series, pBR series, pUC series, pBluescriptII series, pGEM series, pTZ series, pCL series, pSK series, pSKH series, and pET series can be used as plasmid vectors. Specifically, pDZ, pDC, pDCM2, pACYC177, pACYC184, pCL, pSK, pSKH130, pECCG117, pUC19, pBR322, pMW118, pCC1BAC vectors, etc. can be used.

[0111] For example, a polynucleotide encoding a target polypeptide can be inserted into a chromosome via a vector for intracellular chromosomal insertion. The insertion of the polynucleotide into the chromosome can be achieved by any method known in the art, for example, homologous recombination, but is not limited thereto. A selection marker for confirming the chromosomal insertion can be additionally included. The selection marker is used to select cells transformed with the vector, i.e., to confirm the insertion of the target nucleic acid molecule. Markers that confer a selectable phenotype, such as drug resistance, nutrient requirement, cytotoxic agent resistance, or expression of a surface polypeptide, can be used. In an environment treated with a selective agent, only cells expressing the selection marker survive or exhibit other phenotypic traits, so that transformed cells can be selected.

[0112] The term "transformation" in this application refers to introducing a vector containing a polynucleotide encoding a target polypeptide into a host cell or microorganism so that the polypeptide encoded by the polynucleotide can be expressed in the host cell. The transformed polynucleotide may be located within the chromosome of the host cell or located extrachromosomally, as long as it can be expressed in the host cell. In addition, the polynucleotide includes DNA and / or RNA encoding the target polypeptide. The polynucleotide may be introduced in any form as long as it can be introduced into the host cell and expressed. For example, the polynucleotide may be introduced into the host cell in the form of an expression cassette, which is a genetic construct containing all elements necessary for autonomous expression. The expression cassette may typically include a promoter, a transcription termination signal, a ribosome binding site, and a translation termination signal, all of which are operably linked to the polynucleotide. The above expression cassette may be in the form of a self-replicating expression vector. Furthermore, the polynucleotide may be introduced into a host cell in its own form and operably linked to a sequence necessary for expression in the host cell, but is not limited thereto.

[0113] As used herein, the term "operably linked" refers to a configuration in which a regulatory sequence is positioned appropriately to direct the expression of a coding sequence. Therefore, "operably linked" includes a regulatory region of a functional domain with known or desired activity, such as a promoter, terminator, signal sequence, or enhancer region, attached or linked to a target (gene or polypeptide) so as to regulate the expression, secretion, or function of the target in accordance with said known or desired activity. For example, it refers to a polynucleotide sequence that is operatively linked to a promoter sequence that initiates and mediates transcription of the polynucleotide encoding the target variant polypeptide of the present application.

[0114] As used herein, the term “expression” includes, but is not limited to, any step involved in the production of a polypeptide, such as transcription, post-transcriptional modification, translation, post-translational modification, and secretion.

[0115] As used herein, the term "expression vector" means a linear or circular nucleic acid molecule comprising a coding sequence and regulatory sequences operably linked thereto for expression thereof.

[0116] As used herein, the term "regulatory sequence" refers to a polynucleotide sequence necessary for the expression of a coding sequence. Each regulatory sequence may be native to the coding sequence (having the same origin) or foreign (derived from another gene). Examples of the regulatory sequence include a leader sequence, a polyadenylation sequence, a propeptide sequence, a promoter, a signal peptide sequence, an operator sequence, a sequence encoding a ribosome binding site, and sequences that regulate transcription and translation termination. The minimum unit of the regulatory sequence may include a promoter, a transcription and translation termination sequence.

[0117] In relation to a cell, polynucleotide, polypeptide, or vector, the term "recombinant" in this application means that the cell, polynucleotide, polypeptide, or vector has been modified by the introduction of a heterologous nucleic acid or polypeptide or by alteration of a native polynucleotide or polypeptide, or that the cell is derived from a cell so modified. Thus, for example, a recombinant cell may express a gene not found in the native (non-recombinant) form of the cell, or may express a native gene that is expressed or not expressed at all, or otherwise abnormally expressed.

[0118]

[0119] For example, the microorganism producing the L-alanine may be a microorganism into which a sequence encoding a protein comprising an amino acid sequence of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, or SEQ ID NO: 7 has been introduced, or a protein comprising an amino acid sequence having at least 60%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 99.5%, 99.7%, or 99.9% homology or identity with the amino acid sequence of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, or SEQ ID NO: 7 has been introduced.

[0120] For example, the microorganism producing the L-alanine may be a microorganism that inherently includes a base sequence capable of encoding a protein comprising an amino acid sequence having at least 80% homology with the amino acid sequence of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, or SEQ ID NO: 7; a base sequence of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, or SEQ ID NO: 8; or a base sequence having at least 60%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, and less than 100% homology or identity with the base sequence of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, or SEQ ID NO: 8.

[0121]

[0122] For example, the microorganism with increased L-alanine production capacity of the present application may be a microorganism with increased L-alanine production capacity compared to a non-modified microorganism, but is not limited thereto. For example, the non-modified microorganism, which is the target strain for comparison of increased L-alanine production capacity, may be the ATCC13869 strain, but is not limited thereto.

[0123] For example, the microorganism with increased L-alanine productivity has an L-alanine productivity of about 150% or more, specifically, about 150% or more, about 200% or more, about 250% or more, about 260% or more, about 270% or more, about 280% or more, about 290% or more, about 300% or more, about 310% or more, about 320% or more, about 325% or more, about 326% or more, about 327% or more, about 328% or more, about 329% or more, about 330% or more, about 331% or more, about 332% or more, about 333% or more, about 334% or more, about 335% or more, or about 336% or more (the upper limit is not particularly limited, for example, about 1000%) The productivity may be increased by, but is not limited to, about 500% or less, about 400% or less, about 390% or less, about 380% or less, about 370% or less, about 360% or less, about 350% or less, or about 340% or less, as long as it has a positive value of increase compared to the productivity of the parent strain or unmodified microorganism before the mutation. In another example, the recombinant strain with increased L-alanine productivity may have an L-alanine productivity increased by about 1.5 times or more, about 2 times or more, about 2.5 times or more, about 2.6 times or more, about 2.7 times or more, about 2.8 times or more, about 2.9 times or more, about 3 times or more, about 3.1 times or more, about 3.2 times or more, about 3.26 times or more, about 3.3 times or more, or about 3.36 times or more (the upper limit is not particularly limited, and may be, for example, about 10 times or less, about 5 times or less, about 4 times or less, about 3.7 times or less, about 3.5 times or less, or about 3.4 times or less) compared to the parent strain before mutation or the unmodified microorganism, but is not limited thereto.

[0124]

[0125] For example, the microorganism having the ability to produce L-alanine may be either a prokaryotic cell or a eukaryotic cell, but may specifically be a prokaryotic cell. The prokaryotic cell may include, for example, a microbial strain belonging to the genus Escherichia sp., Erwinia sp., Serratia sp., Providencia sp., Corynebacteria sp., Pseudomonas sp., Leptospira sp., Salmonella sp., Brevibacteria sp., Hypomononas sp., Chromobacterium sp., and Norcardia sp., or a fungus or yeast. Specifically, it is a strain of a microorganism belonging to the genus Escherichia, the genus Corynebacterium, and the genus Leptospira, as well as yeast. More specifically, it may be a strain of a microorganism belonging to the genus Corynebacterium.

[0126] As a microorganism according to any one of the preceding specific examples, the microorganism of the present application may be a microorganism of the genus Corynebacterium.

[0127] As an example of the present application, the microorganism of the present application is Corynebacterium glutamicum, Corynebacterium crudilactis, Corynebacterium deserti, Corynebacterium efficiens, Corynebacterium callunae, Corynebacterium stationis, Corynebacterium singulare, Corynebacterium halotolerans, Corynebacterium striatum, Corynebacterium ammoniagenes, Corynebacterium It may be Corynebacterium pollutisoli, Corynebacterium imitans, Corynebacterium testudinoris, or Corynebacterium flavescens. Specifically, the microorganism of the present application may be a microorganism of the genus Corynebacterium, more specifically, Corynebacterium glutamicum or Corynebacterium stationis, but is not limited thereto.

[0128] Meanwhile, it has already been known that microorganisms of the genus Corynebacterium can produce L-alanine, but their production ability is significantly low, and neither the genes nor the mechanism acting on the production mechanism have been fully elucidated. Therefore, the Corynebacterium microorganism having L-alanine production ability of the present application may include a natural wild-type microorganism itself, a Corynebacterium microorganism having improved L-alanine production ability by increasing or decreasing the activity of a gene related to the L-alanine production mechanism, or a Corynebacterium microorganism having improved L-alanine production ability by introducing or increasing the activity of an external gene.

[0129]

[0130] The microorganism having L-alanine production ability of the present application may be a microorganism having improved L-alanine production ability by additionally strengthening the introduced alanine dehydrogenase activity, but is not limited thereto.

[0131] The microorganism of the present application may include any microorganism with additionally enhanced alanine dehydrogenase activity introduced by various known methods.

[0132]

[0133] Another aspect of the present application provides a method for producing L-alanine, comprising the step of culturing a Corynebacterium genus microorganism having L-alanine production ability, into which the activity of the alanine dehydrogenase of the present application has been introduced, in a medium.

[0134] In one specific example, the alanine dehydrogenase may be from Bacillus licheniformis, Bacillus amyloliquefaciens, or Raceella sacchari.

[0135] In this application, the term "cultivation" refers to growing the strain of this application under appropriately controlled environmental conditions. The cultivation process of this application can be performed using any suitable medium and culture conditions known in the art. This cultivation process can be easily adjusted and used by those skilled in the art depending on the selected strain. Specifically, the cultivation may be batch, continuous, and / or fed-batch, but is not limited thereto.

[0136] In this application, the term "medium" refers to a material containing nutrients as a main component necessary for culturing the microorganism of this application, and supplies nutrients and growth factors, including water, which is essential for survival and growth. Specifically, the medium and other culture conditions used for culturing the strain of this application may be any medium used for culturing general microorganisms without particular limitation. However, the microorganism of this application may be cultured under aerobic conditions in a general medium containing an appropriate carbon source, nitrogen source, phosphorus source, inorganic compound, amino acid, and / or vitamin, while controlling temperature, pH, etc. For example, a culture medium for a strain of the genus Corynebacterium can be found in the literature ["Manual of Methods for General Bacteriology" by the American Society for Bacteriology (Washington DC, USA, 1981)].

[0137] In the present application, the carbon source may include carbohydrates such as glucose, saccharose, lactose, fructose, sucrose, maltose, etc.; sugar alcohols such as mannitol, sorbitol, etc.; organic acids such as pyruvic acid, lactic acid, citric acid, etc.; amino acids such as glutamic acid, methionine, lysine, etc. In addition, natural organic nutrients such as starch hydrolysate, molasses, blackstrap molasses, rice winter, cassava, sugarcane bagasse, and corn steep liquor may be used, and specifically, carbohydrates such as glucose and sterilized pretreated molasses (i.e., molasses converted to reducing sugar) may be used, and other appropriate amounts of carbon sources may be used in various ways without limitation. These carbon sources may be used alone or in combination of two or more, but are not limited thereto.

[0138] The nitrogen source may include inorganic nitrogen sources such as ammonia, ammonium sulfate, ammonium chloride, ammonium acetate, ammonium phosphate, ammonium carbonate, ammonium nitrate, etc.; organic nitrogen sources such as amino acids such as glutamic acid, methionine, glutamine, etc.; peptone, NZ-amine, meat extract, yeast extract, malt extract, corn steep liquor, casein hydrolysate, fish or its decomposition product, defatted soybean cake or its decomposition product, etc. These nitrogen sources may be used alone or in combination of two or more, but are not limited thereto.

[0139] The above-mentioned components may include potassium phosphate monobasic, potassium phosphate dibasic, or their corresponding sodium-containing salts. Inorganic compounds may include sodium chloride, calcium chloride, iron chloride, magnesium sulfate, iron sulfate, manganese sulfate, calcium carbonate, etc. In addition, amino acids, vitamins, and / or suitable precursors may be included. These components or precursors may be added to the medium in batch or continuous manner, but are not limited thereto.

[0140] In addition, during the cultivation of the microorganism of the present application, compounds such as ammonium hydroxide, potassium hydroxide, ammonia, phosphoric acid, sulfuric acid, etc. may be added to the medium in an appropriate manner to adjust the pH of the medium. In addition, during the cultivation, foaming may be suppressed by using an antifoaming agent such as fatty acid polyglycol ester. In addition, to maintain the aerobic state of the medium, oxygen or an oxygen-containing gas may be injected into the medium, or to maintain the anaerobic and microaerobic state, nitrogen, hydrogen, or carbon dioxide gas may be injected without gas injection, but is not limited thereto.

[0141] In the culture of the present application, the culture temperature can be maintained at 27 to 37°C, specifically 30 to 33°C, and the culture can be performed for about 20 to 120 hours, but is not limited thereto.

[0142] In the present application, the term "culture" means a culture solution, concentrated culture solution, dried product of culture solution, culture filtrate, concentrated culture filtrate, or dried product of culture filtrate obtained by culturing a specific microorganism in a culture medium, wherein the culture solution means that it contains a specific microorganism, and the culture filtrate means that it does not substantially contain a specific microorganism (here, substantially means that a specific microorganism separated by filtration or the like is excluded, but does not mean that the filtrate is completely free of microorganisms). The culture is not limited in its formulation, and may be, for example, a liquid, an emulsion, or a solid. Specifically, for the purpose of the present application, the culture may contain L-alanine.

[0143] In this application, the term "fermentation" refers to a process in which microorganisms use their enzymes to decompose organic matter, but not to a putrefaction reaction. While fermentation and putrefaction occur through similar processes, if the resulting decomposition produces useful substances, it is called fermentation. If the resulting decomposition produces foul-smelling or harmful substances, it is called putrefaction.

[0144] In the present application, the method for obtaining a fermented product from the strain is not particularly limited, and can be obtained according to a method commonly used in the relevant technical field or a similar field.

[0145] In the present application, the term "fermentation" includes all kinds of materials including a fermentation product produced from the strain, such as not only the fermented material itself, but also a culture medium of the strain in which the strain and the culture coexist, a fermentation product obtained by filtering the strain from the culture medium, a fermentation product obtained by sterilizing the strain from the culture medium and filtering it, an extract obtained by extracting the fermentation product or a culture medium containing it, a diluted solution obtained by diluting the fermentation product or its extract, a concentrate obtained by drying the fermentation product or its extract, a lysate obtained by capturing and crushing the cells of the strain, etc.

[0146] In the method of the present application, any culture conditions and methods known in the art can be used to cultivate microorganisms. Those skilled in the art can easily adjust and use these culture processes according to the selected strain.

[0147] L-alanine produced by the culture of the present invention may be secreted into the medium or remain within the cells.

[0148]

[0149] In one specific embodiment, the method for producing L-alanine of the present application may further include a step of preparing a microorganism of the present application, a step of preparing a medium for culturing the strain, or a combination thereof (in any order), for example, prior to the culturing step.

[0150] The L-alanine production method of the present application may further include a step of recovering the target substance, specifically L-alanine, from the cultured microorganism, a culture of the microorganism, a fermented product of the microorganism, or the culture medium. The recovering step may be additionally included after the culturing step.

[0151] The above recovery may be performed by collecting the target L-alanine using a suitable method known in the art according to the culture method of the microorganism of the present application, for example, a batch, continuous or fed-batch culture method. For example, various chromatographies such as centrifugation, filtration, treatment with a crystallized protein precipitant (salting out method), extraction, ultrasonic disruption, ultrafiltration, dialysis, molecular sieve chromatography (gel filtration), adsorption chromatography, ion exchange chromatography, affinity chromatography, HPLC or a combination thereof may be used, and the target substance, specifically L-alanine, may be recovered from the medium or microorganism using a suitable method known in the art.

[0152] Additionally, the L-alanine production method of the present application may additionally include a purification step. The purification may be performed using any suitable method known in the art. In one example, if the L-alanine production method of the present application includes both a recovery step and a purification step, the recovery step and the purification step may be performed sequentially or discontinuously, regardless of the order, or may be performed simultaneously or integrated into a single step, but is not limited thereto.

[0153] In the method of the present application, alanine dehydrogenase, introduction of activity, and L-alanine, etc. are as described in the other embodiments above.

[0154]

[0155] Another aspect of the present application provides a composition for producing L-alanine, comprising a Corynebacterium genus microorganism having L-alanine production ability into which the activity of alanine dehydrogenase of the present application has been introduced, a culture of the microorganism, a fermented product of the microorganism, or a combination of two or more thereof.

[0156] In one specific example, the alanine dehydrogenase may be from Bacillus licheniformis, Bacillus amyloliquefaciens, or Raceella sacchari.

[0157] The composition of the present application may further comprise any suitable excipient commonly used in compositions for producing L-alanine, and such excipients may be, for example, but are not limited to, preservatives, wetting agents, dispersing agents, suspending agents, buffering agents, stabilizers, or isotonic agents.

[0158] In one specific example, each component present in the composition of the present application may be included in a microbiologically effective amount, or an amount that can be suitably present in the composition for production.

[0159] In the composition of the present application, alanine dehydrogenase, introduction of activity, and L-alanine, etc. are as described in the other embodiments above.

[0160]

[0161] Another aspect of the present application provides a use for producing L-alanine by a microorganism of the genus Corynebacterium having L-alanine production ability, into which the activity of alanine dehydrogenase of the present application is introduced.

[0162] In one specific example, the alanine dehydrogenase may be from Bacillus licheniformis, Bacillus amyloliquefaciens, or Raceella sacchari.

[0163] In the present application, alanine dehydrogenase, introduction of activity and L-alanine, etc. are as described in the other embodiments above.

[0164]

[0165] The present application will be described in more detail below through examples. However, the following examples are merely preferred embodiments intended to illustrate the present application and are therefore not intended to limit the scope of the present application. Furthermore, technical details not described herein can be readily understood and implemented by those skilled in the technical field of the present application or similar fields.

[0166]

[0167] Example 1: Evaluation of L-alanine production ability of L-alanine-producing microorganisms introduced with foreign alanine dehydrogenase - 1

[0168]

[0169] Example 1-1: Production of a vector for introducing a foreign alanine dehydrogenase gene

[0170]

[0171] To create a strain in which a foreign alanine dehydrogenase was introduced into Corynebacterium glutamicum ATCC13869, a vector for introducing genes encoding four types of alanine dehydrogenase was created.

[0172] Specifically, a vector containing each gene linked to the Pcj7 promoter was constructed.

[0173] First, the intergenic region was selected as the copy insertion site, and the restriction enzyme XbaI, XhoI (tctagactcgag) sequences were inserted at the NCgl2195 downstream position, and 1.0 kb of homologous region was provided on both sides. Next, the chromosomal gene of the Corynebacterium glutamicum ATCC13869 strain was isolated using the G-spin Total DNA extraction mini kit (Cat. No. 17045) from Intron according to the protocol provided in the kit, and the gene fragments (NCgl2195down_A, NCgl2195down_B) were obtained through polymerase chain reaction using the primer pairs of SEQ ID NO: 22 and SEQ ID NO: 23 and the primer pairs of SEQ ID NO: 24 and SEQ ID NO: 25, respectively. Polymerase chain reaction conditions were as follows: denaturation at 95°C for 5 min, followed by 30 cycles of denaturation at 95°C for 30 s, annealing at 55°C for 30 s, and polymerization at 72°C for 30 s, followed by polymerization at 72°C for 5 min. The two fragments were ligated to linear pDCM2 (Korean Publication No. 10-2020-0136813) digested with BamHI and SalI using T4 ligase (New England Biolab, Beverly, A). The vector thus constructed was named pDCM2-ΔNCgl2195down.

[0174]

[0175] Each of the four chromosomal genes, ald1 gene (SEQ ID NO: 2) from Bacillus licheniformis, ald2 gene (SEQ ID NO: 4) from Bacillus licheniformis, alaD gene (SEQ ID NO: 6) from Bacillus amyloliquefaciens, or ald2 gene (SEQ ID NO: 8) from Laceyella sacchari, was obtained using the G-spin Total DNA extraction mini kit (Cat. No. 17045) from Intron.

[0176] Specifically, according to the Protocol provided in the above mini kit, the fragments were separated, and through polymerase chain reaction using primer pairs of SEQ ID NO: 9 and SEQ ID NO: 10, SEQ ID NO: 11 and SEQ ID NO: 12, SEQ ID NO: 9 and SEQ ID NO: 13, SEQ ID NO: 14 and SEQ ID NO: 15, SEQ ID NO: 9 and SEQ ID NO: 16, SEQ ID NO: 17 and SEQ ID NO: 18, SEQ ID NO: 9 and SEQ ID NO: 19, and SEQ ID NO: 20 and SEQ ID NO: 21, four Pcj7 promoter fragments that can be joined to four gene fragments each and four gene fragments connected thereto (ald1 (B.li), ald2 (B.li), ald2 (L.sa), alaD (B.am)) were obtained. Polymerase chain reaction conditions were as follows: denaturation at 95°C for 5 minutes, followed by 30 cycles of denaturation at 95°C for 30 seconds, annealing at 55°C for 30 seconds, and polymerization at 72°C for 30 seconds, followed by polymerization at 72°C for 5 minutes. As a result, four polynucleotides of 364 bp each of Pcj7 and 1,276 bp each of ald1 (B. li), 1,283 bp each of ald2 (B. li), 1,271 bp each of alaD (B. am), and 1,274 bp each of ald2 (L. sa) were obtained.

[0177] The two fragments (Pcj7 and each gene) were ligated into linear pDCM2-ΔNCgl2195down digested with XbaI and XhoI using T4 ligase (New England Biolab, Beverly, A). The vectors thus constructed were named pDCM2-ΔNCgl2195down::Pcj7_ald1 (B.li), pDCM2-ΔNCgl2195down::Pcj7_ald2 (B.li), pDCM2-ΔNCgl2195down::Pcj7_alaD (B.am), and pDCM2-ΔNCgl2195down::Pcj7_ald2 (L.sa), respectively.

[0178]

[0179] 서열번호명칭서열9Pcj7_F_N2195downGAGATAGAGGTCTTTACGtctagaagaaacatcccagcgc10Pcj7_R_ald1(B.li)CTTTAGGAA TTCCAATGATCATgagtgtttccttcgttggg11ald1(B.li)_F_Pcj7gtacccaacgaaaggaaacactcATGATCATTGGAATTCCTA AAG12ald(B.li)_R_N2195downGTGAAGGAAAGAGTTCctcgagTTAAAGCAGAATGGAAAAAAGG13Pcj7_R_ald2(B.li)CTTTC GGTACGCCGATAATCATgagtgtttccttcgttg14ald2(B.li)_F_Pcj7gtacccaacgaaaggaaacactcATGATTATCGGCGTACC G15ald2(B.li)_R_N2195downGAAGGAAAGAGTTCctcgagCTGCAATTGCGGCAAAATTG16Pcj7_R_alaD(B.am)GAACCCCGAT AATCATgagtgtttccttcgttg17alaD(B.am)_F_Pcj7caacgaaaggaaacactcATGATTATCGGGGTTC18alaD(B.am)_R_N2 195downGTGAAGGAAAGAGTTCctcgagTCCGGGATATGAATTGATATTC19Pcj7_R_ald2(L.sa)CTGTTGGCACTCCTACTTTCATGA gtgtttccttcgttgggtac20ald2(L.sa)_F_Pcj7gtacccaacgaaaggaaacactcATGAAAGTAGGAGTGCCAACAG21ald2(L.sa)_R_N2195downGAAGGAAAGAGTTCctcgagGCTCCATCGTTTCAAACG22N2195down_AFctcggtacccggggatccTTCCCATGGAAACTCTCG23N2195down_ARGTGTGAAGGAAAGAGTTCc tcgagtctagaCGTAAAGACCTCTATC24N2195down_BFGAGATAGAGGTCTTTACGtctagactcgagGAACTCTTTCCTTCAC25N2195down_BRcatgcctgcaggtcgacTTGATGAGCAGCAGTGG.

[0180]

[0181] Example 1-2: Production of microorganisms introducing foreign alanine dehydrogenase

[0182]

[0183] The four types of vectors pDCM2-ΔNCgl2195down::Pcj7_ald1(B.li), pDCM2-ΔNCgl2195down::Pcj7_ald2(B.li), pDCM2-ΔNCgl2195down::Pcj7_alaD(B.am), and pDCM2-ΔNCgl2195down::Pcj7_ald2(L.sa) produced in the above Example 1-1 were each transformed into the parent strain Corynebacterium glutamicum ATCC13869 by electroporation, and then strains in which the mutant gene and vector were inserted together on the chromosome were selected as the first candidate group in a selection medium containing 25 mg / L of kanamycin. Afterwards, the final strain was obtained by introducing the endogenous ΔNCgl2195down gene intergenic region on the chromosome through a second crossover process using the homology of the gene on the existing chromosome and the gene inserted through the vector, and the vector including the kanamycin resistance gene was removed. The introduced strain was first confirmed through PCR using the primer pair of SEQ ID NO: 26 and SEQ ID NO: 27, and then finally confirmed through gene sequence analysis. The strains into which Pcj7_ald1(B.li), Pcj7_ald2(B.li), Pcj7_alaD(B.am), and Pcj7_ald2(L.sa) were introduced through the above method were named CJ0183, CJ0184, CJ0192, and CJ0185.

[0184]

[0185] Sequence number name sequence 26N2195down_CFCACCTGGGATGGCAGCAAACTTGAACTTG27N2195down_CRCAGGATGTTTGGGCTGGTGAATCATAG

[0186]

[0187] Example 1-3: Evaluation of L-alanine production capacity of L-alanine-producing microorganisms introduced with foreign alanine dehydrogenase.

[0188]

[0189] In order to confirm the L-alanine productivity of Corynebacterium glutamicum CJ0183, CJ0184, CJ0192, and CJ0185 produced in the above Examples 1-2, they were cultured using the following method.

[0190] The parent strain, Corynebacterium glutamicum ATCC13869, and the four mutant strains were each inoculated into a 250 ml corner-baffle flask containing 25 ml of the seed medium, and the culture was shaken at 200 rpm for 20 hours at 30°C to obtain a seed culture solution. Thereafter, 1 ml of the seed culture solution was inoculated into a 250 ml corner-baffle flask containing 24 ml of the production medium, and cultured at 30°C for 48 hours at 200 rpm to produce L-alanine.

[0191] After completion of cultivation, the amount of L-alanine produced was measured using liquid high-performance chromatography (Agilent, 1260 Infinity LC system), and the amount of L-alanine produced in the culture medium for each strain tested was measured. The compositions of the seed medium and production medium are as follows, and the concentration of L-alanine in the culture medium for each strain tested is shown in Table 3 below.

[0192]

[0193] <Jongbaeji>

[0194] Glucose (anhydrous glucose) 20g / L, Polypeptone 10g / L, Yeast extract 10g / L, (NH4)2SO410g / L, Urea 1.5g / L, KH2PO45.2g / L, K2HPO410.7g / L, d-Biotin 1.8mg / L, Thiamine-HCl 9mg / L, CAPA 9mg / L, NCA 60mg / L, MGSO40.5g / L

[0195]

[0196] <Production medium>

[0197] CaCO330g / L, Sucrose 57g / L, BM 6g / L, MgSO40.5g / L, (NH4)2SO450g / L, KH2PO41g / L, Yeast extract 2g / L, Ammonium acetate 6.28g / L, d-Biotin 0.05mg / L, Thiamine-HCl 0.1mg / L, MnSO46.7mg / L, FeSO410mg / L

[0198]

[0199] ATCC13869 (parent strain) CJ0183 CJ0184 CJ0192 CJ0185 L-alanine concentration (g / L) 6.1 20.5 19.9 18.9 15.2

[0200]

[0201] As a result, as shown in Table 3 above, the parent strain Corynebacterium glutamicum ATCC13869 produced L-alanine at a concentration of 6.1 g / L, but the foreign introduced strains CJ0183, CJ0184, CJ0192, and CJ0185 according to the present application produced L-alanine at concentrations of 20.5 g / L, 19.9 g / L, 18.9 g / L, and 15.2 g / L, respectively, confirming that L-alanine productivity increased by 336%, 326%, 310%, and 250% compared to the parent strain.

[0202] Accordingly, it was confirmed that L-alanine can be produced in high concentrations in a microorganism of the genus Corynebacterium by introducing the alanine dehydrogenase of the present application.

[0203]

[0204] Example 2: Evaluation of L-alanine production ability of L-alanine-producing microorganisms introduced with foreign alanine dehydrogenase - 2

[0205]

[0206] Example 2-1: Production of a recombinant vector with added copies of a foreign alanine dehydrogenase gene

[0207]

[0208] In order to produce a strain in which one copy of foreign alanine dehydrogenase was additionally introduced into the CJ0183 and CJ0184 strains produced in the above Example 1-2, a copy of the gene encoding alanine dehydrogenase of the ald1 gene (SEQ ID NO: 2) derived from Bacillus licheniformis was added in a form linked to the Pcj7 promoter.

[0209]

[0210] First, the intergenic region was selected as the copy insertion site, and the restriction enzymes NotI and XhoI (gcggccgcctcgag) sequences were inserted at the NCgl1292down stream position, and 1.0 kb of homologous region was provided on both sides. Next, the chromosomal gene of the Corynebacterium glutamicum ATCC13869 strain was isolated using the G-spin Total DNA extraction mini kit (Cat. No. 17045) from Intron Co., Ltd. according to the protocol provided in the kit, and the gene fragments (NCgl1292down_A, NCgl1292down_B) were obtained through polymerase chain reaction using the primer pairs of SEQ ID NOs: 28 and 29 and the primer pairs of SEQ ID NOs: 30 and 31, respectively. Polymerase chain reaction conditions were as follows: denaturation at 95°C for 5 min, followed by 30 cycles of denaturation at 95°C for 30 s, annealing at 55°C for 30 s, and polymerization at 72°C for 30 s, followed by polymerization at 72°C for 5 min. The two fragments were ligated to linear pDCM2 (Korean Publication No. 10-2020-0136813) digested with BamHI and SalI using T4 ligase (New England Biolab, Beverly, A). The vector thus constructed was named pDCM2-ΔNCgl1292down.

[0211]

[0212] Using the pDCM2-ΔNCgl2195down::Pcj7_ald1(B.li) constructed in Example 1-1 as a template, a polymerase chain reaction was performed using the primer pair of SEQ ID NO: 32 and SEQ ID NO: 33. The conditions were denaturation at 95°C for 5 minutes, followed by 30 cycles of denaturation at 95°C for 30 seconds, annealing at 55°C for 30 seconds, and polymerization at 72°C for 30 seconds, and then polymerization at 72°C for 5 minutes. As a result, a 1,598-bp polynucleotide of Pcj7_ald1(B.li) was obtained. This fragment was ligated to linear pDCM2-ΔNCgl1292down digested with NotI and XhoI using T4 ligase (New England Biolab, Beverly, A). The vector prepared in this way was named pDCM2-ΔNCgl1292down::Pcj7_ald1(B.li).

[0213]

[0214] SEQ ID NO: Name Sequence 28N1292dw_AFgagctcggtacccggggatccGTTTTCTACAATAAATTGAGTTAG29N1292dw_ARCAACCGGACGCATGGCActcgaggcggccgcGAAAAAGGCTTTCG30N1292dw_BFCGAAAGCCTTTTTCgcggccgcctcgagTGCCATGCGTCCG GTTG31N1292dw_BRcatgcctgcaggtcgacCGCTCATTGGGTACGG32Pcj7_ald1(B.li)_F_N1292GAAAGCCTTTTTCg cggccgcAGAAACATCCCAGCGCTAC33ald1(B.li)_R_N1292CTTCACAACCGGACGCATGGCActcgagTTAAAGCAGAATGG

[0215]

[0216] Example 2-2: Production of microorganisms with added copies of foreign alanine dehydrogenase genes

[0217]

[0218] The pDCM2-ΔNCgl1292down::Pcj7_ald1(B.li) vector constructed in Example 2-1 was transformed into the parent strains CJ0183 and CJ0184 by electroporation, and then strains in which the mutant gene and the vector were inserted together on the chromosome were selected as primary candidates on a selection medium containing 25 mg / L of kanamycin. Thereafter, a second crossover process using the homology between the gene on the existing chromosome and the gene inserted through the vector was performed, and 1 copy of ald1(B.li) was added to the endogenous ΔNCgl1292down gene region on the chromosome, and the vector including the kanamycin resistance gene was removed, thereby obtaining the final strain. The final strain was initially confirmed through PCR using the primer pair of SEQ ID NO: 34 and SEQ ID NO: 35, and then finally confirmed through gene sequence analysis. The strains obtained using the above method and additionally introduced with Pcj7_ald1 (B.li) were named CJ0242 and CJ0229, respectively. That is, CJ0242 is a strain in which 2 copies of B.li ald1 were added compared to ATCC13869, and CJ0229 is a strain in which 1 copy of B.li ald1 and 1 copy of B.li ald2 were added compared to ATTC13869.

[0219]

[0220] Sequence number name sequence 34N1292down_CFCAGTCAATAGGTAGTCCCGATCCCAAG35N1292down_CRGAACTAACGAAGAAGGACGCCTAAGAGAC

[0221]

[0222] Example 2-3: Evaluation of L-alanine production ability of L-alanine-producing microorganisms with added copies of foreign alanine dehydrogenase genes

[0223]

[0224] In order to confirm the L-alanine productivity of Corynebacterium glutamicum CJ0242 and CJ0229 produced in Example 2-2 above, they were cultured using the following method.

[0225] The parent strain, Corynebacterium glutamicum ATCC13869, and the five mutant strains were each inoculated into a 250 ml corner-baffle flask containing 25 ml of the seed medium, and the mixture was shaken and cultured at 200 rpm for 20 hours at 30°C to obtain a seed culture solution. Thereafter, 1 ml of the seed culture solution was inoculated into a 250 ml corner-baffle flask containing 24 ml of the production medium, and cultured at 30°C for 48 hours at 200 rpm to produce L-alanine.

[0226] After completion of cultivation, the amount of L-alanine produced was measured using liquid high-performance chromatography, and the amount of L-alanine produced in the culture medium for each strain tested was measured. The composition of the seed medium and production medium is the same as in Example 1-3, and the concentration of L-alanine in the culture medium for each strain tested is shown in Table 6 below.

[0227]

[0228] CJ0183 (parent strain) CJ0242 CJ0184 (parent strain) CJ0229 L-alanine concentration (g / L) 38.240.837.441.5

[0229]

[0230] As a result, as shown in Table 6 above, the parent strain CJ0183 produced L-alanine at a concentration of 38.2 g / L, but strain CJ0242, into which one copy was additionally introduced to the foreign strain according to the present application, produced L-alanine at a concentration of 40.8 g / L, confirming that L-alanine productivity increased by 107% compared to the parent strain. In addition, the parent strain CJ0184 produced L-alanine at a concentration of 37.4 g / L, and strain CJ0229, into which one copy was additionally introduced to the foreign strain according to the present application, produced L-alanine at a concentration of 41.5 g / L, confirming that L-alanine productivity increased by 111% compared to the parent strain.

[0231] Accordingly, it was confirmed that L-alanine can be produced at a high concentration by additionally introducing the number of copies into a Corynebacterium microorganism into which the foreign alanine dehydrogenase of the present application has been introduced.

[0232]

[0233] From the above description, those skilled in the art will understand that the present application can be implemented in other specific forms without altering its technical concept or essential characteristics. In this regard, it should be understood that the embodiments described above are illustrative in all respects and not restrictive. The scope of this application should be interpreted to include all changes or modifications derived from the meaning and scope of the following claims and their equivalents, rather than the detailed description above.

Claims

1. A microorganism of the genus Corynebacterium having L-alanine production ability with the activity of alanine dehydrogenase introduced therein. The above alanine dehydrogenase is a microorganism of the genus Corynebacterium, which is derived from Bacillus licheniformis, Bacillus amyloliquefaciens, or Raceella sacchari.

2. A microorganism of the genus Corynebacterium, wherein the alanine dehydrogenase in the first paragraph is encoded by the ald1, ald2, or alaD gene.

3. A microorganism of the genus Corynebacterium, wherein the alanine dehydrogenase comprises an amino acid sequence of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, or SEQ ID NO:

7.

4. A microorganism of the genus Corynebacterium, wherein the gene encoding the alanine dehydrogenase comprises a base sequence of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, or SEQ ID NO: 8 in the first paragraph.

5. In the first paragraph, the microorganism of the genus Corynebacterium is Corynebacterium glutamicum.

6. A Corynebacterium microorganism according to any one of claims 1 to 5, wherein the Corynebacterium microorganism has increased L-alanine production ability compared to a non-modified microorganism.

7. A method for producing L-alanine, comprising the step of culturing a Corynebacterium genus microorganism having L-alanine production ability and having alanine dehydrogenase activity introduced therein, in a medium. A method for producing L-alanine, wherein the alanine dehydrogenase is derived from Bacillus licheniformis, Bacillus amyloliquefaciens, or Raceella sacchari.

8. A method according to claim 7, further comprising a step of recovering a target substance from the cultured microorganism, a culture of the microorganism, a fermented product of the microorganism, or the culture medium.

9. A composition for producing L-alanine, comprising a Corynebacterium genus microorganism having L-alanine production ability with introduced alanine dehydrogenase activity, a culture of the microorganism, a fermented product of the microorganism, or a combination of two or more thereof. A composition for producing L-alanine, wherein the alanine dehydrogenase is derived from Bacillus licheniformis, Bacillus amyloliquefaciens, or Raceella sacchari.

10. For the production of L-alanine by a microorganism of the genus Corynebacterium into which the activity of alanine dehydrogenase has been introduced. The above alanine dehydrogenase is derived from Bacillus licheniformis, Bacillus amyloliquefaciens, or Raceella sacchari.